DANVERS, Mass., Feb. 8 /PRNewswire-FirstCall/ -- Medwave Inc. , the innovator in sensor-based, non-invasive blood pressure measuring solutions, announced today that it will report fiscal first quarter results on February 14, 2006. The Company will hold a conference call on February 14, 2006 at 2:00 p.m. Eastern Time to discuss its quarterly results, business highlights and outlook. In addition, the Company may answer one or more questions concerning business and financial developments and trends, as well as the Company’s view on earnings forecasts and other business and financial matters affecting the Company, some of the responses to which may contain information that has not been previously disclosed.
The conference call may be accessed via telephone by dialing in to USA toll free number: 1-877-989-4936. After dialing in, participants will be asked for a passcode. The passcode is MEDWAVE. Tim O’Malley, President and CEO of Medwave, will be leading the conference. The conference call will be recorded, and an audio file will be available to the public later that day on Medwave’s website. To access the audio file, go to http://www.medwave.com , select Medwave The Company, and click on Investor Info, or type in the following address to go directly to the page: http://www.medwave.com/medinvq.htm .
Medwave, Inc. develops, manufactures, and distributes sensor-based non-invasive blood pressure solutions. Its Vasotrac(R) APM205A NIBP Monitor, the Vasotrac(R) APM205A Model DS, and the MJ23 OEM Module are new approaches to non-invasive blood pressure monitoring. Medwave’s Legato(TM) OEM Developers Kit is designed to introduce the innovative Vasotrac(R) technology to OEM designers. The Primo(TM) Non-Invasive Blood Pressure Monitoring System, Medwave’s latest innovation, is designed to be sold into the point of care blood pressure monitoring market, estimated to be in the $600 Million per year range. Medwave has received the necessary regulatory clearances to market its technology in Europe, Asia, and the United States. Medwave’s technology is installed in over 500 hospitals and clinics worldwide. Medwave has received the Seal of Acceptance from the Alliance of Children’s Hospitals, as well as the Frost & Sullivan Market Engineering Award for Technology Innovation and the Frost & Sullivan Customer Value Enhancement Award. Medwave currently has supply and/or other agreements with Nihon Kohden, Zoll Medical Corporation, Analogic Corporation, and a global electronics company. Medwave trades on the NASDAQ small cap market under the symbol MDWV. For more information, visit http://www.medwave.com .
Medwave Inc.
CONTACT: Investors-Media, Jodie Chastain of Medwave, Inc.,+1-800-894-7601, jchastain@mdwv.com
